Global Lancets Market Analysis and Forecast 2025-2031

Summary

According to APO Research, The global Lancets market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Lancets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Lancets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Lancets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Lancets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Lancets include ARKRAY, Ascensia, B. Braun, BD, Cardinal Health, Greiner Bio One, HemoCue, HTL-STREFA and ICU Medical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Lancets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Lancets, also provides the sales of main regions and countries. Of the upcoming market potential for Lancets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lancets sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Lancets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Lancets sales, projected growth trends, production technology, application and end-user industry.

Lancets Segment by Company

ARKRAY
Ascensia
B. Braun
BD
Cardinal Health
Greiner Bio One
HemoCue
HTL-STREFA
ICU Medical
I-SENS
Lifescan
Nipro
Owen Mumford
Sarstedt
Terumo
UltiMed
Guangzhou iCare Medical
Roche
Sinocare
Shandong Lianfa
SteriLance Medical
Tianjin Huahong
Abbott
Yicheng
Yuwell

Lancets Segment by Type

Safety Lancets
Ordinary Lancets

Lancets Segment by Application

Children's Fingertip Blood Tests
Glucose Tests
Others

Lancets Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lancets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lancets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lancets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Lancets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Lancets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lancets sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Lancets Market by Type
1.2.1 Global Lancets Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Safety Lancets
1.2.3 Ordinary Lancets
1.3 Lancets Market by Application
1.3.1 Global Lancets Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Children's Fingertip Blood Tests
1.3.3 Glucose Tests
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Lancets Market Dynamics
2.1 Lancets Industry Trends
2.2 Lancets Industry Drivers
2.3 Lancets Industry Opportunities and Challenges
2.4 Lancets Industry Restraints
3 Global Market Growth Prospects
3.1 Global Lancets Revenue Estimates and Forecasts (2020-2031)
3.2 Global Lancets Revenue by Region
3.2.1 Global Lancets Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Lancets Revenue by Region (2020-2025)
3.2.3 Global Lancets Revenue by Region (2026-2031)
3.2.4 Global Lancets Revenue Market Share by Region (2020-2031)
3.3 Global Lancets Sales Estimates and Forecasts 2020-2031
3.4 Global Lancets Sales by Region
3.4.1 Global Lancets Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Lancets Sales by Region (2020-2025)
3.4.3 Global Lancets Sales by Region (2026-2031)
3.4.4 Global Lancets Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Lancets Revenue by Manufacturers
4.1.1 Global Lancets Revenue by Manufacturers (2020-2025)
4.1.2 Global Lancets Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Lancets Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Lancets Sales by Manufacturers
4.2.1 Global Lancets Sales by Manufacturers (2020-2025)
4.2.2 Global Lancets Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Lancets Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Lancets Sales Price by Manufacturers (2020-2025)
4.4 Global Lancets Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Lancets Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Lancets Manufacturers, Product Type & Application
4.7 Global Lancets Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Lancets Market CR5 and HHI
4.8.2 2024 Lancets Tier 1, Tier 2, and Tier 3
5 Lancets Market by Type
5.1 Global Lancets Revenue by Type
5.1.1 Global Lancets Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Lancets Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Lancets Revenue Market Share by Type (2020-2031)
5.2 Global Lancets Sales by Type
5.2.1 Global Lancets Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Lancets Sales by Type (2020-2031) & (K Units)
5.2.3 Global Lancets Sales Market Share by Type (2020-2031)
5.3 Global Lancets Price by Type
6 Lancets Market by Application
6.1 Global Lancets Revenue by Application
6.1.1 Global Lancets Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Lancets Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Lancets Revenue Market Share by Application (2020-2031)
6.2 Global Lancets Sales by Application
6.2.1 Global Lancets Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Lancets Sales by Application (2020-2031) & (K Units)
6.2.3 Global Lancets Sales Market Share by Application (2020-2031)
6.3 Global Lancets Price by Application
7 Company Profiles
7.1 ARKRAY
7.1.1 ARKRAY Comapny Information
7.1.2 ARKRAY Business Overview
7.1.3 ARKRAY Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 ARKRAY Lancets Product Portfolio
7.1.5 ARKRAY Recent Developments
7.2 Ascensia
7.2.1 Ascensia Comapny Information
7.2.2 Ascensia Business Overview
7.2.3 Ascensia Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Ascensia Lancets Product Portfolio
7.2.5 Ascensia Recent Developments
7.3 B. Braun
7.3.1 B. Braun Comapny Information
7.3.2 B. Braun Business Overview
7.3.3 B. Braun Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 B. Braun Lancets Product Portfolio
7.3.5 B. Braun Recent Developments
7.4 BD
7.4.1 BD Comapny Information
7.4.2 BD Business Overview
7.4.3 BD Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 BD Lancets Product Portfolio
7.4.5 BD Recent Developments
7.5 Cardinal Health
7.5.1 Cardinal Health Comapny Information
7.5.2 Cardinal Health Business Overview
7.5.3 Cardinal Health Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Cardinal Health Lancets Product Portfolio
7.5.5 Cardinal Health Recent Developments
7.6 Greiner Bio One
7.6.1 Greiner Bio One Comapny Information
7.6.2 Greiner Bio One Business Overview
7.6.3 Greiner Bio One Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Greiner Bio One Lancets Product Portfolio
7.6.5 Greiner Bio One Recent Developments
7.7 HemoCue
7.7.1 HemoCue Comapny Information
7.7.2 HemoCue Business Overview
7.7.3 HemoCue Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 HemoCue Lancets Product Portfolio
7.7.5 HemoCue Recent Developments
7.8 HTL-STREFA
7.8.1 HTL-STREFA Comapny Information
7.8.2 HTL-STREFA Business Overview
7.8.3 HTL-STREFA Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 HTL-STREFA Lancets Product Portfolio
7.8.5 HTL-STREFA Recent Developments
7.9 ICU Medical
7.9.1 ICU Medical Comapny Information
7.9.2 ICU Medical Business Overview
7.9.3 ICU Medical Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 ICU Medical Lancets Product Portfolio
7.9.5 ICU Medical Recent Developments
7.10 I-SENS
7.10.1 I-SENS Comapny Information
7.10.2 I-SENS Business Overview
7.10.3 I-SENS Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 I-SENS Lancets Product Portfolio
7.10.5 I-SENS Recent Developments
7.11 Lifescan
7.11.1 Lifescan Comapny Information
7.11.2 Lifescan Business Overview
7.11.3 Lifescan Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Lifescan Lancets Product Portfolio
7.11.5 Lifescan Recent Developments
7.12 Nipro
7.12.1 Nipro Comapny Information
7.12.2 Nipro Business Overview
7.12.3 Nipro Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Nipro Lancets Product Portfolio
7.12.5 Nipro Recent Developments
7.13 Owen Mumford
7.13.1 Owen Mumford Comapny Information
7.13.2 Owen Mumford Business Overview
7.13.3 Owen Mumford Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Owen Mumford Lancets Product Portfolio
7.13.5 Owen Mumford Recent Developments
7.14 Sarstedt
7.14.1 Sarstedt Comapny Information
7.14.2 Sarstedt Business Overview
7.14.3 Sarstedt Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Sarstedt Lancets Product Portfolio
7.14.5 Sarstedt Recent Developments
7.15 Terumo
7.15.1 Terumo Comapny Information
7.15.2 Terumo Business Overview
7.15.3 Terumo Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Terumo Lancets Product Portfolio
7.15.5 Terumo Recent Developments
7.16 UltiMed
7.16.1 UltiMed Comapny Information
7.16.2 UltiMed Business Overview
7.16.3 UltiMed Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 UltiMed Lancets Product Portfolio
7.16.5 UltiMed Recent Developments
7.17 Guangzhou iCare Medical
7.17.1 Guangzhou iCare Medical Comapny Information
7.17.2 Guangzhou iCare Medical Business Overview
7.17.3 Guangzhou iCare Medical Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 Guangzhou iCare Medical Lancets Product Portfolio
7.17.5 Guangzhou iCare Medical Recent Developments
7.18 Roche
7.18.1 Roche Comapny Information
7.18.2 Roche Business Overview
7.18.3 Roche Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 Roche Lancets Product Portfolio
7.18.5 Roche Recent Developments
7.19 Sinocare
7.19.1 Sinocare Comapny Information
7.19.2 Sinocare Business Overview
7.19.3 Sinocare Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.19.4 Sinocare Lancets Product Portfolio
7.19.5 Sinocare Recent Developments
7.20 Shandong Lianfa
7.20.1 Shandong Lianfa Comapny Information
7.20.2 Shandong Lianfa Business Overview
7.20.3 Shandong Lianfa Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.20.4 Shandong Lianfa Lancets Product Portfolio
7.20.5 Shandong Lianfa Recent Developments
7.21 SteriLance Medical
7.21.1 SteriLance Medical Comapny Information
7.21.2 SteriLance Medical Business Overview
7.21.3 SteriLance Medical Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.21.4 SteriLance Medical Lancets Product Portfolio
7.21.5 SteriLance Medical Recent Developments
7.22 Tianjin Huahong
7.22.1 Tianjin Huahong Comapny Information
7.22.2 Tianjin Huahong Business Overview
7.22.3 Tianjin Huahong Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.22.4 Tianjin Huahong Lancets Product Portfolio
7.22.5 Tianjin Huahong Recent Developments
7.23 Abbott
7.23.1 Abbott Comapny Information
7.23.2 Abbott Business Overview
7.23.3 Abbott Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.23.4 Abbott Lancets Product Portfolio
7.23.5 Abbott Recent Developments
7.24 Yicheng
7.24.1 Yicheng Comapny Information
7.24.2 Yicheng Business Overview
7.24.3 Yicheng Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.24.4 Yicheng Lancets Product Portfolio
7.24.5 Yicheng Recent Developments
7.25 Yuwell
7.25.1 Yuwell Comapny Information
7.25.2 Yuwell Business Overview
7.25.3 Yuwell Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
7.25.4 Yuwell Lancets Product Portfolio
7.25.5 Yuwell Recent Developments
8 North America
8.1 North America Lancets Market Size by Type
8.1.1 North America Lancets Revenue by Type (2020-2031)
8.1.2 North America Lancets Sales by Type (2020-2031)
8.1.3 North America Lancets Price by Type (2020-2031)
8.2 North America Lancets Market Size by Application
8.2.1 North America Lancets Revenue by Application (2020-2031)
8.2.2 North America Lancets Sales by Application (2020-2031)
8.2.3 North America Lancets Price by Application (2020-2031)
8.3 North America Lancets Market Size by Country
8.3.1 North America Lancets Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Lancets Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Lancets Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
8.3.6 Mexico
9 Europe
9.1 Europe Lancets Market Size by Type
9.1.1 Europe Lancets Revenue by Type (2020-2031)
9.1.2 Europe Lancets Sales by Type (2020-2031)
9.1.3 Europe Lancets Price by Type (2020-2031)
9.2 Europe Lancets Market Size by Application
9.2.1 Europe Lancets Revenue by Application (2020-2031)
9.2.2 Europe Lancets Sales by Application (2020-2031)
9.2.3 Europe Lancets Price by Application (2020-2031)
9.3 Europe Lancets Market Size by Country
9.3.1 Europe Lancets Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Lancets Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Lancets Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
9.3.9 Spain
9.3.10 Netherlands
10 China
10.1 China Lancets Market Size by Type
10.1.1 China Lancets Revenue by Type (2020-2031)
10.1.2 China Lancets Sales by Type (2020-2031)
10.1.3 China Lancets Price by Type (2020-2031)
10.2 China Lancets Market Size by Application
10.2.1 China Lancets Revenue by Application (2020-2031)
10.2.2 China Lancets Sales by Application (2020-2031)
10.2.3 China Lancets Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Lancets Market Size by Type
11.1.1 Asia Lancets Revenue by Type (2020-2031)
11.1.2 Asia Lancets Sales by Type (2020-2031)
11.1.3 Asia Lancets Price by Type (2020-2031)
11.2 Asia Lancets Market Size by Application
11.2.1 Asia Lancets Revenue by Application (2020-2031)
11.2.2 Asia Lancets Sales by Application (2020-2031)
11.2.3 Asia Lancets Price by Application (2020-2031)
11.3 Asia Lancets Market Size by Country
11.3.1 Asia Lancets Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Lancets Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Lancets Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Lancets Market Size by Type
12.1.1 SAMEA Lancets Revenue by Type (2020-2031)
12.1.2 SAMEA Lancets Sales by Type (2020-2031)
12.1.3 SAMEA Lancets Price by Type (2020-2031)
12.2 SAMEA Lancets Market Size by Application
12.2.1 SAMEA Lancets Revenue by Application (2020-2031)
12.2.2 SAMEA Lancets Sales by Application (2020-2031)
12.2.3 SAMEA Lancets Price by Application (2020-2031)
12.3 SAMEA Lancets Market Size by Country
12.3.1 SAMEA Lancets Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Lancets Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Lancets Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Lancets Value Chain Analysis
13.1.1 Lancets Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Lancets Production Mode & Process
13.2 Lancets Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Lancets Distributors
13.2.3 Lancets Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings